AlphaYouCP
Schedule 13D filing
Celadon Partners SPV 24 disclosed a 54.6% stake in Senti Biosciences Holdings, Inc. (SNTI)
Celadon Partners SPV 24 reported owning 54.6% of Senti Biosciences Holdings, Inc. (SNTI) (25,748,890 shares) in a Schedule 13D filed Sep 11, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 11, 2026
- Source
- Schedule 13D
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.